Bowen Acquisition Corp Reports Q1 2026 Financial Results with Improved Net Loss

Bowen Acquisition Corp has reported its financial results for the first quarter of 2026, revealing a net loss of $20,822, a significant improvement compared to a net loss of $2,039,997 in the same period of the previous year. The company’s operating costs decreased to $65,709 from $134,736 year-over-year, reflecting a reduction in expenses associated with its formation and operations. Additionally, the company recorded other income of $44,887, primarily from interest earned on investments held in its trust account, which totaled $67,475 for the quarter, down from $97,321 in the prior year.

As of March 31, 2026, Bowen Acquisition Corp reported total assets of $7,954,443, a slight increase from $7,933,900 at the end of 2025. The company’s cash and cash equivalents decreased to $6,996 from $12,280, while investments held in the trust account rose to $7,741,246 from $7,673,771. The company’s liabilities remained relatively stable, with total current liabilities reported at $2,671,953, compared to $2,630,588 at the end of the previous fiscal year. The shareholders’ deficit increased to $2,458,756 from $2,370,459, primarily due to the accumulated deficit growing from $2,370,686 to $2,458,983.

In terms of strategic developments, Bowen Acquisition Corp is actively pursuing a business combination with Shenzhen Qianzhi BioTechnology Co. Ltd. The company has extended the deadline for completing this business combination to December 31, 2026, following shareholder approvals. The company has also entered into a Prepaid Forward Purchase Agreement (FPA) to facilitate the acquisition, which includes provisions for purchasing shares from public shareholders. As of the latest filing, the FPA liability stood at $1,121,420, reflecting a change in fair value of $22,693 for the quarter.

Operationally, Bowen Acquisition Corp has not yet commenced any revenue-generating activities, as it remains focused on identifying and executing its initial business combination. The company has maintained a consistent number of ordinary shares outstanding at 2,266,500, with 673,396 shares subject to possible redemption. The company’s management has expressed concerns regarding its ability to continue as a going concern, citing a working capital deficit and the need for additional financing to cover operational costs and pursue its business combination plans.

Looking ahead, Bowen Acquisition Corp aims to finalize its business combination with Qianzhi and is exploring various financing options to address its working capital needs. The company is also considering alternative strategies, including seeking to have its securities quoted on the OTC market to maintain its public trading status. However, management has acknowledged the uncertainty surrounding these plans and the potential implications for the company’s future operations.